By Josh Beckerman

Eli Lilly & Co.'s (LLY) Type 2 diabetes drug Trulicity has been approved by the U.S. Food and Drug Administration, the agency said Thursday.

The drug is a subcutaneous injection that helps improve blood sugar levels.

The FDA is requiring certain postmarketing studies for Trulicity.

Write to Josh Beckerman at josh.beckerman@wsj.com

Access Investor Kit for Eli Lilly & Co.

Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US5324571083

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Eli Lilly Charts.
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Eli Lilly Charts.